Lesotho vs Other small states: Access to anti-retroviral drugs, female
Lesotho
98.0%
in 2024
Other small states
94.0%
in 2022
Lesotho rank
1st
Other small states rank
1st
Access to anti-retroviral drugs, female over time
- Lesotho
- Other small states
How they compare
Lesotho currently reports 98.0% against 94.0% in Other small states, a difference of 4.0%.
The two have swapped places 2 times across 20 shared years of data; in 2000 it was Other small states ahead.
Lesotho ranks 1st and Other small states ranks 1st of 141 countries.
Across the 3 decades both report, Lesotho averaged higher in 1 and Other small states in 2.
Head to head by decade
| Decade | Lesotho | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.9% | 7.2% | 0.7% | Lesotho |
| 2010s | 55.4% | 62.1% | 6.7% | Other small states |
| 2020s | 88.0% | 93.8% | 5.8% | Other small states |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lesotho or Other small states?
- Lesotho, at 98.0% against 94.0% in Other small states as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lesotho and Other small states?
- 4.0%, with Lesotho ahead.
- How many years of comparable data are there for Lesotho and Other small states?
- 20 years are reported by both, from 2000 to 2022.
- How do Lesotho and Other small states rank globally for access to anti-retroviral drugs, female?
- Lesotho ranks 1st and Other small states ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.